Gilead stock

Nov 5, 2014
61
1
18
#1
Anyone know why Gilead is plummeting? Is it still a good long term position or is this selloff an indicator that something is going wrong with the company?
 

ACstudio

Active member
Sep 7, 2014
138
14
28
#2
Anyone know why Gilead is plummeting? Is it still a good long term position or is this selloff an indicator that something is going wrong with the company?
GILD (the ticker is quicker)
There are several news stories on this. The Thinkorswim news feed shows related news stories the second they break. If you don't have TOS try freestockcharts.com they will show related news as well.
It's a biotech....They do this a lot. I treat them as a potential take over/bankruptcy play. Means if I do anything... I'm in and out.
 
Mar 15, 2011
34
1
18
#3
Anyone know why Gilead is plummeting? Is it still a good long term position or is this selloff an indicator that something is going wrong with the company?
are you a longer term investment (6-month +) or is it just a trade?

longer term it is fine and if you are inclined in that way i would just buy some more around 97 or 91 if we can get that low, glad i seen your post actually because i will be buying this stock!

its merely a standard market sell off, no reason what so ever this stock should crash.. this company is 92% institutionally owned. it has risen huge over the past 5 years..

all the fundamentals look incredible from its history.. i would hold this stock and buy more at a cheaper level .

dm me so we can discus this stock as it is new to me since i 1st read your post but after doing a small amount of research it seems to be gold!! speak soon

Michael A Ball
 
Mar 25, 2018
54
3
8
#4
GILD (the ticker is quicker)
There are several news stories on this. The Thinkorswim news feed shows related news stories the second they break. If you don't have TOS try freestockcharts.com they will show related news as well.
It's a biotech....They do this a lot. I treat them as a potential take over/bankruptcy play. Means if I do anything... I'm in and out.
Gilead stock looks slightly undervalued at this point because the market is undervaluing Gilead’s HIV and oncology portfolios. The company also shows significant potential in the immunology/NASH area.